SEC Contract Filing

Filing Date: 2018-05-31

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>exhibit101spa.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit101spa</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:791;"><!-- exhibit101spa001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit101spa001.jpg" title="slide1" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white"> Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this &#8220;Agreement&#8221;) is dated as of May 29, 2018, between Fibrocell Science, Inc., a Delaware corporation (the &#8220;Company&#8221;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#8220;Purchaser&#8221; and collectively the &#8220;Purchasers&#8221;). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) as to the Shares and (ii) an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder as to the Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows: ARTICLE I. DEFINITIONS 1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1: &#8220;Acquiring Person&#8221; shall have the meaning ascribed to such term in Section 4.5. &#8220;Action&#8221; shall have the meaning ascribed to such term in Section 3.1(j). &#8220;Affiliate&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act. &#8220;Board of Directors&#8221; means the board of directors of the Company. &#8220;Business Day&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. &#8220;Closing&#8221; means the closing of the purchase and sale of the Securities pursuant to Section 2.1. &#8220;Closing Date&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&#8217; obligations to pay the Subscription Amount and (ii) the Company&#8217;s obligations to deliver the Securities, in each case, have been </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit101spa002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit101spa002.jpg" title="slide2" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white"> satisfied or waived, but in no event later than the second (2nd) Trading Day following the date hereof. &#8220;Commission&#8221; means the United States Securities and Exchange Commission. &#8220;Common Stock&#8221; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed. &#8220;Common Stock Equivalents&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. &#8220;Company Counsel&#8221; means Hogan Lovells US LLP, with offices located at 1735 Market Street, 23rd Floor Philadelphia, PA 19103. &#8220;Disclosure Schedules&#8221; means the Disclosure Schedules of the Company delivered concurrently herewith. &#8220;Disclosure Time&#8221; means, (i) if this Agreement is signed on any day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless otherwise instructed to an earlier time by the Placement Agent (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise instructed to an earlier time by the Placement Agent. &#8220;Evaluation Date&#8221; shall have the meaning ascribed to such term in Section 3.1(s). &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. &#8220;Exempt Issuance&#8221; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding